RecruitingNCT02421718

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation


Sponsor

University Medical Center Groningen

Enrollment

10,000 participants

Start Date

Mar 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

Motive: In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from lung cancer patients. Goal: To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life. A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following lung cancer patients who have received a meaningful dose of radiation therapy into a structured long-term follow-up program to track their health, cancer progression, and quality of life over time. **You may be eligible if...** - You have been diagnosed with non-small cell lung cancer (NSCLC), limited-stage small cell lung cancer, thymoma, or lung tumors treated with stereotactic radiotherapy - You received a radiation dose greater than 40 Gy as part of your treatment **You may NOT be eligible if...** - You do not meet the above criteria (i.e., you received a lower radiation dose, or have a different cancer type) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiotherapy

Locations(1)

University Medical Center Groningen

Groningen, Provincie Groningen, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02421718


Related Trials